Expertise in
1
conditions

Yi-chun J. Liu

No.135, Nanhsiao Street, 500, 
Chang-hua, TNQ, TW 
Expertise in
1
conditions
No.135, Nanhsiao Street, 500, 
Chang-hua, TNQ, TW 

Overview

Yi-chun Liu practices practicing medicine in Chang-hua, Taiwan.

Liu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Nasopharyngeal Carcinoma, Precocious Puberty, Schizoaffective Disorder, Drug Induced Dyskinesia, and Hemorrhoidectomy.

They are actively involved in clinical research, co-authoring 78 peer reviewed articles and participating in 2 clinical trials.

Locations

No.135, Nanhsiao Street, 500, Chang-hua, TNQ, Taiwan
Other Locations
Kaohsiung, KHQ, Taiwan
Taitung, TNQ, Taiwan
Dawan, TNQ 10617, Taiwan
TPQ 10617, Taiwan
Taoyuan, TNQ, Taiwan
Hsinchu, TNQ, Taiwan
Taipei, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA But Without Clinically Detectable Residual Diseases and/or Metastases After Curative Chemoradiation - A Single Arm Phase II Trial
Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA But Without Clinically Detectable Residual Diseases and/or Metastases After Curative Chemoradiation - A Single Arm Phase II Trial
Enrollment Status: Terminated
Publish Date: April 11, 2023
Intervention Type: Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Long Term, Open-Label, Multi-Center Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
A Long Term, Open-Label, Multi-Center Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
Enrollment Status: Completed
Publish Date: March 18, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

78 Total Publications

Diagnostic probability change across follow-up: a Bayesian EHR cohort study in psychiatry.
Diagnostic probability change across follow-up: a Bayesian EHR cohort study in psychiatry.
Journal: Diagnosis (Berlin, Germany)
Published: February 10, 2026

Frequently Asked Questions about Yi-chun J. Liu

Is Yi-chun J. Liu a top-rated expert for Nasopharyngeal Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Yi-chun J. Liu is classified as an Advanced expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yi-chun J. Liu participate in research or clinical trials?

Yes. Yi-chun J. Liu has published 78 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Yi-chun J. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile